期刊文献+

人前列腺癌细胞骨转移潜能差异表达蛋白的研究 被引量:6

Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency
原文传递
导出
摘要 目的研究人前列腺癌不同骨转移潜能细胞株的差异表达蛋白质图谱,筛选前列腺癌骨转移相关蛋白并探讨其功能。方法应用蛋白质组学和免疫印迹等方法比较和筛选来源相同但具有不同骨转移潜能的前列腺癌细胞株(PC-3/骨转移亚克隆T3B/淋巴结转移亚克隆P2-4)的蛋白质表达差异。构建高迁移率族蛋白1(HMGB1)的真核表达载体Pgenesil-1/HMGB1siRNA转染至高骨转移潜能的T3B细胞中,通过动物实验观察HMGB1对前列腺癌细胞骨转移的影响。结果蛋白质组学技术获得6个有意义的蛋白质,分别参与细胞骨架构成、转录调控、磷酸化过程和物质代谢等功能。成功构建siRNA表达载体Pgenesil-1/HMGB1siRNA,转染后可使T3B细胞HMGB1的蛋白表达水平显著降低(P〈0.05)。动物实验显示,抑制HMGB1表达可明显降低T3B细胞的骨转移能力(P〈0.05)。结论高骨转移潜能的前列腺癌细胞株中存在与前列腺癌骨转移相关的蛋白质,HMGB1与前列腺癌骨转移密切相关。应用siRNA干扰技术能有效地抑制HMGB1基因的表达,同时也能有效抑制前列癌细胞的骨转移能力。 Objective To investigate the differential protein expression profiles of human prostatic carcinoma cells with different metastatic tendency and to screen the osseous metastasis associated proteins and investigate their function. Methods Proteomics and Western blotting were applied to screen and identify the differentially expressed proteins in the prostatic carcinoma cells of different lines: line T3B with high osseous metastasis potential, line P2-4 with high lymphatic metastasis potential, and their common parent cell line PC-3. The eukaryotic expression vector carrying human Pgenesil-1/HMGBlsiRNA was constructed and transfected into T3B cells by Lipofectamine 2000 and the positive clones was screened by G418. Pgenesil-1/HMGBlsiRNA/T3B, Pgenesil-1/T3B, and T3B cells were inoculated into the left ventricles of nude mice. Twelve weeks later the mice were killed. The number of osseous metastatic nodules and osseous metastasis inhibition rate were calculated. The mice metastatic tumor cells were identified by immunohistochemistry. Result Six differential expressed proteins, correlated with cystoskeleton, transcriptional control, cellular metabolism, and phosphorylation were identified by proteomics and Western blotting. The recombinant plasmid Pgenesil-1/HMGBlsiRNA was successfully constructed. The HMGB1 expression of the T3B cells transfected with Pgenesil-1/HMGBlsiRNA was significantly lower than those of the other 2 groups (both P 〈 0.05 ). The number of osseous metastatic nodules of the mice inoculated with Pgenesil-1/HMGBlsiRNA/T3B was significantly less than those of the other 2 groups (both P 〈 0.05 ). The metastatic osseous tumor cells were identified as the human prostatic carcinoma cells. Conclusion Osseous metastasis associated proteins exist in prostatic carcinoma cells of the hne with high osseous metastasis potential. HMGB1 is closely related to the osseous metastasis of human prostatic carcinoma cells, siRNA targeting HMGB1 specifically suppresses the expression of HMGB1 gene in the human prostatic carcinoma cells with high osseous metastasis potential and effectively inhibits the osseous metastasis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第17期1197-1201,共5页 National Medical Journal of China
基金 国家“973”重点基础研究发展规划基金资助项目(2002CB513100)
关键词 前列腺肿瘤 肿瘤转移 骨肿瘤 Prostatic neoplasms Neoplasms metastasis Bone neoplasms
  • 相关文献

参考文献14

  • 1佟明,艾军魁,袁亦明,殷毅,周利群,辛殿旗,李鸣,那彦群.SRD5A2基因A49T多态性与前列腺癌风险性关系的研究[J].中华医学杂志,2005,85(19):1319-1321. 被引量:2
  • 2廖晖,陈安民,郭风劲,李锋,罗政强,宋登新,陈超.不同骨转移潜能人前列腺癌细胞亚株的筛选[J].中国癌症杂志,2007,17(3):231-235. 被引量:5
  • 3Yonou H, Yokose T, Kamijo T, et al. Establishment of a novel species-and tissue-specific metastasis model of human prostate in humanized no-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res ,2001,61:2177-2182.
  • 4侯树坤,徐涛.前列腺癌骨转移分子生物学特征与治疗对策[J].实用肿瘤杂志,2002,17(4):217-219. 被引量:3
  • 5Letizia TM, Chiarugi P, Cirri P,et al. β-Catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res, 2002, 62:6489-6499.
  • 6Taguchi A, Blood DC, del Toro G, et al. Blockage of RAGE- amphoterin signalling suppresses tumor growth and metastasis. Nature, 2000, 405:354-360.
  • 7Oue N, Aung PP, Mitani Y, et al. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Ontology, 2005, 69 Suppl 1:17-22.
  • 8Sasahira T, Akama Y, Fujii K, et al. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch, 2005, 446:411-415.
  • 9Rauvala H, Huttunen HJ, Fages C, et al. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell mobility. Matrix Biol,2000,19 :377-387.
  • 10Kuniyasu H, Chihara Y, Kondo H, et al. Differential effects between amphoterin and advanced glycation end products on colon cancer cell. Int J Cancer, 2003, 104:722-727.

二级参考文献17

  • 1司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 2Jaffe AM, Malkowicz SB, Walker AH, et al. Association of SRD5A2 genotype and pathological characteristics of prostate tumors. Cancer Res, 2000,60: 1626-1630.
  • 3Landis SH, Murray T, Bolden S, et al, Cancer statistics 1999. CA Cancer J Clin,1999, 9: 5-11.
  • 4Andersson S, Russell DW, Structure and biochemical properties of cloned and expressed human and rat steroid 5-α reductases. Proc Natl Acad Sci USA, 1990, 87: 3640-3644.
  • 5Makridakis N, Ross RK, Pike MC, et al, Association of missence substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angles USA. Lancet, 1999, 8: 975-978.
  • 6Monomen N, Ikonen T, Syrjakoski K, et al, A missence substitution A49T in the steroid 5-α reductase gene (SRD5A2) is not associated with prostate cancer in Fanland. Br J cancer, 2001,1344-1347.
  • 7Cher ML.Mechanisms governing bone metastasis in prostate cancer[J].Curr Opin Urol,2001,11(5):483-488.
  • 8Chambers AF,Groom AC,MacDonald IC.Dissemination and growth of cancer cells in metastatic sites[J].Nat Rev Cancer,2002,2(8):563-572.
  • 9Nemeth JA,Yousif R,Herzog M,et al.Matrix metalloproteinase activity,bone matrix turnover,and tumor cell proliferation in prostate cancer bone metastasis[J].J Natl Cancer Inst,2002,94(1):17-25.
  • 10Angelucci A,Festuccia C,D'Andrea G,et al.Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators[J].Biol Chem,2002,383(1):229-234.

共引文献11

同被引文献31

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部